TELA Bio, Inc. (TELA) stock
TELANasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$0.76+0.00 (+0.07%)
Close on Nov 17, 2026Market cap $34.21MP/E –Yield –
TELA Bio total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
TELA Bio's total debt was $56.08M at Jun 30, 2026. For fiscal 2025 it was $55.65M, up 35.3% from the year before.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $55.65M | +35.3% |
| FY2024 | Dec 31, 2024 | $41.12M | +1.5% |
| FY2023 | Dec 31, 2023 | $40.52M | +1.5% |
| FY2022 | Dec 31, 2022 | $39.92M | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $56.08M | +35.5% |
| Q1 FY2026 | Mar 31, 2026 | $55.87M | +35.4% |
| Q4 FY2025 | Dec 31, 2025 | $55.65M | +35.3% |
| Q3 FY2025 | Sep 30, 2025 | $41.49M | +1.3% |
| Q2 FY2025 | Jun 30, 2025 | $41.38M | +1.4% |
| Q1 FY2025 | Mar 31, 2025 | $41.28M | +1.5% |
| Q4 FY2024 | Dec 31, 2024 | $41.12M | +1.5% |
| Q3 FY2024 | Sep 30, 2024 | $40.97M | +1.5% |
| Q2 FY2024 | Jun 30, 2024 | $40.82M | +1.5% |
| Q1 FY2024 | Mar 31, 2024 | $40.67M | +1.5% |
| Q4 FY2023 | Dec 31, 2023 | $40.52M | +1.5% |
| Q3 FY2023 | Sep 30, 2023 | $40.36M | +1.5% |
| Q2 FY2023 | Jun 30, 2023 | $40.21M | +1.5% |
| Q1 FY2023 | Mar 31, 2023 | $40.06M | – |
| Q4 FY2022 | Dec 31, 2022 | $39.92M | – |
| Q3 FY2022 | Sep 30, 2022 | $39.77M | – |
| Q2 FY2022 | Jun 30, 2022 | $39.62M | – |
See a number that looks wrong?